⚠️ No article content returned.
Pfizer, Inc. (PFE)
- Written by: Madison Wilson
Latest Company News
GSK plc's ViiV Healthcare announces positive findings from a phase I study on cabotegravir ultra long-acting for HIV treatment. Exciting progress in long-acting medication development.
ViiV Healthcare announces promising results from LATITUDE phase III trial, showing long-acting HIV treatment Cabenuva's superiority over daily oral therapy.
